University of Sao Paulo
Stimulation with pyridostigmine may be a therapy option for vagal dysfunction
Published in Pharma Law Weekly, November 2nd, 2004
According to researchers in Brazil, "Impaired parasympathetic modulation increases the risk for sudden death in patients with heart diseases. Therefore, cholinergic stimulation may have a potential protective role. The aim of [our] study was to verify the effects of pyridostigmine bromide, a reversible cholinesterase inhibitor, on heart rate (HR), blood pressure (BP), HR and BP variability, and baroreflex sensitivity (BS).
P.P. Soares and colleagues of the University of Sao Paulo wrote, "Male Wistar rats were divided in two groups: (1)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2004-11-02)
More Articles from Pharma Law Weekly
- Adherex Technologies, Inc.
Patent issued for method of improving drug delivery to tumors - American Psychological Association
APA applauds passage of Mentally Ill Offender Treatment and Crime Reduction Act - Biofrontera AG
Biotech firm strengthens drug pipeline by acquiring a phase II compound - Capgemini Group
Report finds integrated operations important priority for pharma industry - Centers for Medicare and Medicaid Services
HHS seeks to expand Medicare coverage - CollaGenex Pharmaceuticals, Inc.
Periostat maker files patent infringement claim against IVAX, CorePharma - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
